AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Syntara Ltd

0.024

0.000

Volume:942.21K

Turnover:22.61K

Market Cap:47.09M

PE:-4.42

High:0.024

Open:0.024

Low:0.024

Close:0.024

52wk High:0.040

52wk Low:0.019

Shares:1.96B

Float Shares:1.00B

Volume Ratio:1.17

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.005

EPS(LYR):-0.005

ROE:-59.65%

ROA:-29.81%

PB:2.90

PE(LYR):-4.42

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Syntara Ltd - FY Prelim Revenues from Ordinary Activities and Other Income A$7 Mln

THOMSON REUTERS

Syntara Ltd-azalox Mds Study Advances to Final Phase 1B Cohort

THOMSON REUTERS

Syntara's Parkinson's-Linked Drug Candidate Shows Encouraging Trial Results, Says Euroz Hartleys

MT Newswires Live

Syntara Seeks Trading Halt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/SNT.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SNT.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SNT.AU\",,,,,undefined,":{"symbol":"SNT.AU","market":"AU","secType":"STK","nameCN":"Syntara Ltd","latestPrice":0.024,"timestamp":1789020720000,"preClose":0.024,"halted":0,"volume":942209,"delay":0,"changeRate":0,"nameEN":"Syntara Ltd","floatShares":1004676595,"shares":1961906275,"eps":-0.005429,"marketStatus":"Not Yet Opened","change":0,"latestTime":"09-10 16:12:00 AEST","open":0.024,"high":0.024,"low":0.024,"amount":22613,"amplitude":0,"askPrice":0.025,"askSize":211698,"bidPrice":0.024,"bidSize":451515,"shortable":3,"etf":0,"ttmEps":-0.005429,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.024,"openAndCloseTimeList":[[1788998400000,1789020000000]],"volumeRatio":1.173758,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"SNT.AU","preClose":0.025,"auctionPrice":0.025,"auctionVolume":475614,"auction":3,"marketStatus":"盘后竞价","timestamp":1788847802094}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SNT.AU\",,,,,undefined,":{"symbol":"SNT.AU","floatShares":1004676595,"roa":"-29.81%","roe":"-59.65%","lyrEps":-0.005429,"volumeRatio":1.173758,"shares":1961906275,"dividePrice":0,"high":0.024,"amplitude":0,"preClose":0.024,"low":0.024,"week52Low":0.019,"pbRate":"2.90","psRate":"6.79","week52High":0.04,"institutionHeld":0,"latestPrice":0.024,"committee":0.361599,"eps":-0.005429,"divideRate":0,"volume":942209,"delay":0,"ttmEps":-0.005429,"open":0.024,"prevYearClose":0.035,"prevWeekClose":0.026,"prevMonthClose":0.026,"prevQuarterClose":0.02,"fiveDayClose":0.026,"twentyDayClose":0.026,"sixtyDayClose":0.024},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNT.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-07-28","symbol":"SNT.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1785160800000,"reportTimeType":"","actualEps":null},{"date":"2025-05-01","symbol":"SNT.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1746057600000,"name":null,"time":"","dateTimestamp":1746021600000,"actualEps":null},{"market":"AU","date":"2024-10-29","symbol":"SNT.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1730120400000,"reportTimeType":"pre","actualEps":null},{"date":"2024-04-30","symbol":"SNT.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714435200000,"name":null,"time":"","dateTimestamp":1714399200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNT.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNT.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662203577","title":"Syntara Ltd - FY Prelim Revenues from Ordinary Activities and Other Income A$7 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203577","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203577?lang=en_us&edition=fundamental","pubTime":"2026-08-27 12:50","pubTimestamp":1787806254,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44N19A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","SNT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652268086","title":"Syntara Ltd-azalox Mds Study Advances to Final Phase 1B Cohort","url":"https://stock-news.laohu8.com/highlight/detail?id=2652268086","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652268086?lang=en_us&edition=fundamental","pubTime":"2026-07-20 08:01","pubTimestamp":1784505714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nTUE2TTVLT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","SNT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649973672","title":"Syntara's Parkinson's-Linked Drug Candidate Shows Encouraging Trial Results, Says Euroz Hartleys","url":"https://stock-news.laohu8.com/highlight/detail?id=2649973672","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649973672?lang=en_us&edition=fundamental","pubTime":"2026-07-07 07:08","pubTimestamp":1783379325,"startTime":"0","endTime":"0","summary":"Syntara's  positive headline results from a Phase 2 trial of its experimental drug for isolated REM Sleep Behaviour Disorder  indicate that the trial objectives were met, Euroz Hartleys said in a note on Monday.The investment firm said the encouraging results confirm that the drug candidate SNT-4728 is safe and well-tolerated.The trial also enrolled iRBD patients who are at a high risk of developing Parkinson's, making the findings more relevant to the drug's potential use in Parkinson's disease.The brokerage sees a significant potential market opportunity due to the lack of approved treatments for iRBD.Euroz Hartleys maintained a speculative buy rating on Syntara with a price target of $0.16.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","SNT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648463921","title":"Syntara Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2648463921","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648463921?lang=en_us&edition=fundamental","pubTime":"2026-07-03 07:23","pubTimestamp":1783034618,"startTime":"0","endTime":"0","summary":"BRIEF-Syntara Seeks Trading HaltJuly 3 (Reuters)-Syntara LtdSNT.AX:TRADING HALT PENDING PRELIMINARY RESULTS FROM IRBD PARKINSON’S DISEASE STUDY OF SNT-4728Further company coverage:SNT.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN4340Y6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNT.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SNT.AU\",params:#limit:6,delay:true,,,undefined,":[]}}